Results 91 to 100 of about 3,899,518 (170)

Toll like receptor agonist effects on human CD8+ T cell activation and expression of T cell checkpoint receptors. [PDF]

Hum Vaccin Immunother
Jeon D, Moseman JE, Hill E, McNeel DG.
europepmc   +1 more source

The path forward for T cell engagers in patients with prostate cancer. [PDF]

J Immunother Cancer
Subudhi SK, Siddiqui BA, Zarrabi KK, Kelly WK, Drake CG.   +4 more
europepmc   +1 more source

Drug-loaded bispecific T cell nanoengager overcomes T cell exhaustion for potent cancer immunotherapy. [PDF]

Proc Natl Acad Sci U S A
Wang J, Huang X, Shi Q, Swingle KL, Hamilton AG, Gong N, Mitchell MJ.   +6 more
europepmc   +1 more source

KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population. [PDF]

J Cancer Res Clin Oncol
Thomas J, Kennedy S, Darcy S, Malaco H, Chambwe N, Kamdar D, Periera L, Salama A, Scarola D, Miles B, Frank D, Seetharamu N, Mandal R.   +12 more
europepmc   +1 more source

Modes of the initiation of T cell-mediated immune responses. [PDF]

Med Rev (2021)
Li L, Yao Z.
europepmc   +1 more source

To modify or not to modify: Rethinking mRNA design for CAR T cell engineering. [PDF]

Mol Ther Nucleic Acids
Thatte AS, Mitchell MJ.
europepmc   +1 more source

Metabolic reprogramming tailors T cell immunity in sepsis. [PDF]

Front Immunol
Xian D, Chen F, Liu B, Wang L.
europepmc   +1 more source

Predictive markers for the efficacy of CAR T-cell therapy: the interplay between CAR T-cell fitness and systemic immunity. [PDF]

Blood Adv
Yoo KH, Szymura S, Dong Z, Kandel A, Cha SC, Kwak LW.   +5 more
europepmc   +1 more source

Indolent peripheral T-cell lymphoma resembling Kimura's disease: a new variant of T-cell Lymphoma? [PDF]

Leuk Res Rep
Sun H, Feng J, Zhang Y, Zhang J, Lu S, Liu Y.   +5 more
europepmc   +1 more source